z-logo
Premium
Pioglitazone: inexpensive; very effective at reducing HbA 1c ; no evidence of bladder cancer risk; plenty of evidence of cardiovascular benefit
Author(s) -
Ryder Robert E. J.,
DeFronzo Ralph A.
Publication year - 2019
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.14053
Subject(s) - medicine , citation , pioglitazone , library science , family medicine , diabetes mellitus , computer science , type 2 diabetes , endocrinology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom